Seres Therapeutics CEO and key executive team

Seres Therapeutics's President, Chief Executive Officer, and Chairman of the Board of Directors is Roger Pomerantz. Seres Therapeutics's key executives include Roger Pomerantz and 11 others.
Roger Pomerantz

Roger Pomerantz

President, Chief Executive Officer, and Chairman of the Board of Directors
John Aunins

John Aunins

Executive Vice President of Bioprocess & Manufacturing and Chief Technology Officer
David Cook

David Cook

Executive Vice President of Research & Development and Chief Scientific Officer
Thomas DesRosier

Thomas DesRosier

Executive Vice President, Chief Legal Officer and Secretary
Matthew Henn

Matthew Henn

Senior Vice President, Head of Drug Discovery & Bioinformatics
Carol Lewis-Cullinan

Carol Lewis-Cullinan

Vice President and Head of Clinical Operations
Barbara McGovern

Barbara McGovern

Vice President and Head of Medical Affairs
Henry Rath

Henry Rath

Senior Vice President, Head of Corporate Development
Eric Shaff

Eric Shaff

Executive Vice President and Chief Financial Officer
Carlo Tanzi

Carlo Tanzi

Senior Director and Head of Investor Relations and Corporate Communications
Michele Trucksis

Michele Trucksis

Executive Vice President and Chief Medical Officer
Jeff York

Jeff York

Vice President and Head of Human Resources
Last updated: